A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Phase 4CompletedNCT00367445

Pfizer30 enrolled

Overview

To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetes mellitus Type 2 Exclusion Criteria: * Severe Asthma, severe COPD * Smoking

Pfizer Investigational Site

Chula Vista, California, United States

Variability of blood glucose over a period of 72 hours

Insulin pharmacokinetics

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.